Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Breast Cancer

  Free Subscription


16.05.2022

1 AJR Am J Roentgenol
2 Ann Oncol
23 Ann Surg Oncol
5 BMC Cancer
1 Breast Cancer
2 Breast Cancer (Dove Med Press)
2 Breast Cancer Res
1 Breast Cancer Res Treat
3 Cancer
1 Cancer Lett
1 Carcinogenesis
1 Eur J Cancer
2 Eur J Surg Oncol
1 Exp Cell Res
3 J Clin Oncol
1 J Surg Oncol
4 NPJ Breast Cancer
1 Oncogene
2 PLoS One
2 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. LAWSON MB, Herschorn SD, Sprague BL, Buist DSM, et al
    Imaging Surveillance Options for Individuals With a Personal History of Breast Cancer: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2022 May 11. doi: 10.2214/AJR.22.27635.
    PubMed         Abstract available


    Ann Oncol

  2. MARCZYK M, Mrukwa A, Yau C, Wolf D, et al
    Treatment Efficacy Score - continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials.
    Ann Oncol. 2022 May 2. pii: S0923-7534(22)00762.
    PubMed         Abstract available

  3. TARANTINO P, Jin Q, Mittendorf EA, King TA, et al
    Clinical and pathological features of breast cancer patients eligible for adjuvant abemaciclib.
    Ann Oncol. 2022 Apr 28. pii: S0923-7534(22)00754.
    PubMed        


    Ann Surg Oncol

  4. LIANG DH, Black D, Yi M, Luo CK, et al
    Clinical Outcomes Using Magnetic Seeds as a Non-wire, Non-radioactive Alternative for Localization of Non-palpable Breast Lesions.
    Ann Surg Oncol. 2022;29:3822-3828.
    PubMed         Abstract available

  5. HUANG CC, Tsai YF, Liu CY, Lien PJ, et al
    Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast Cancers.
    Ann Surg Oncol. 2022;29:3578-3590.
    PubMed         Abstract available

  6. SILVERSTEIN MJ, Epstein MS, Chen P, Lin K, et al
    ASO Visual Abstract: Recurrence and Survival Rates for 1400 Early Breast Tumors Treated with Intraoperative Radiation Therapy (IORT).
    Ann Surg Oncol. 2022;29:3739.
    PubMed        

  7. REDFERN RE, Shermis RB
    ASO Visual Abstract: Initial Experience Using Magseed for Breast Lesion Localization Compared to Wire-Guided Localization-Analysis of Volume and Margin Clearance Rates.
    Ann Surg Oncol. 2022;29:3784.
    PubMed        

  8. MORARASU S, Clancy C, Ghetu N, Musina AM, et al
    Impact of Quilting Sutures on Surgical Outcomes After Mastectomy: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2022;29:3785-3797.
    PubMed         Abstract available

  9. REDFERN RE, Shermis RB
    Initial Experience Using Magseed for Breast Lesion Localization Compared With Wire-Guided Localization: Analysis of Volume and Margin Clearance Rates.
    Ann Surg Oncol. 2022;29:3776-3783.
    PubMed         Abstract available

  10. SILVERSTEIN MJ, Epstein MS, Chen P, Lin K, et al
    Recurrence and Survival Rates for 1400 Early Breast Tumors Treated with Intraoperative Radiation Therapy (IORT).
    Ann Surg Oncol. 2022;29:3726-3736.
    PubMed         Abstract available

  11. MARTINS MAIA C, Siderides C, Jaffer S, Weltz C, et al
    Mastectomy or Margin Re-excision? A Nomogram for Close/Positive Margins After Lumpectomy for DCIS.
    Ann Surg Oncol. 2022;29:3740-3748.
    PubMed         Abstract available

  12. WEISS A, King C, Grossmith S, Portnow L, et al
    How Often Does Retrieval of a Clipped Lymph Node Change Adjuvant Therapy Recommendations? A Prospective, Consecutive, Patient Cohort Study.
    Ann Surg Oncol. 2022;29:3764-3771.
    PubMed         Abstract available

  13. KOPKASH K, Novak K, Murphy R, Deliere A, et al
    ASO Visual Abstract: Improving the Breast Surgeon's Ergonomic Workload for Nipple-Sparing Mastectomies Using Exercise and an Operating Room Positioning Protocol.
    Ann Surg Oncol. 2022;29:3863.
    PubMed        

  14. CORTINA CS, Kong AL
    ASO Author Reflections: The Evolving Multidisciplinary Management of the Axilla in Mastectomy Patients.
    Ann Surg Oncol. 2022;29:3853-3854.
    PubMed        

  15. JU T, Momeni A, Wapnir I
    ASO Author Reflections: Preventing Nipple Loss by Surgical Delay in Nipple-Sparing Mastectomy.
    Ann Surg Oncol. 2022;29:3855-3856.
    PubMed        

  16. MORARASU S, Clancy C, Ghetu N, Musina AM, et al
    ASO Visual Abstract: Impact of Quilting Sutures on Surgical Outcomes After Mastectomy: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2022;29:3799.
    PubMed        

  17. MAIMONE S, McLaughlin SA
    ASO Author Reflections: Optimizing Additional Workups from Preoperative Breast MRI.
    Ann Surg Oncol. 2022;29:3849-3850.
    PubMed        

  18. MAIMONE S, Morozov AP, Li Z, Craver EC, et al
    Additional Workups Recommended During Preoperative Breast MRI: Methods to Gain Efficiency and Limit Confusion.
    Ann Surg Oncol. 2022;29:3839-3848.
    PubMed         Abstract available

  19. BREDBECK BC, Mott NM, Wang T, Sinco BR, et al
    ASO Visual Abstract: Facility-Level Variation of Low-Value Breast Cancer Treatments in Older Women with Early-Stage Breast Cancer: Analysis of a Statewide Claims Registry.
    Ann Surg Oncol. 2022 May 9. pii: 10.1245/s10434-022-11743.
    PubMed        

  20. RELATION T, Ndumele A, Bhattacharyya O, Fisher JL, et al
    Surgery Refusal Among Black and Hispanic Women with Non-Metastatic Breast Cancer.
    Ann Surg Oncol. 2022 May 5. pii: 10.1245/s10434-022-11832.
    PubMed         Abstract available

  21. MAIMONE S, Morozov AP, Li Z, Craver EC, et al
    ASO Visual Abstract: Additional Work-Ups Recommended During Preoperative Breast MRI, Methods to Gain Efficiency and Limit Confusion.
    Ann Surg Oncol. 2022;29:3851-3852.
    PubMed        

  22. MARTINS MAIA C, Siderides C, Jaffer S, Weltz C, et al
    ASO Visual Abstract: Mastectomy or Margin Reexcision? A Nomogram for Close/Positive Margins after Lumpectomy for DCIS.
    Ann Surg Oncol. 2022;29:3749.
    PubMed        

  23. MITSUEDA R, Gen A, Fujiki Y, Gondo N, et al
    ASO Visual Abstract: Satisfaction of Patients Who Received Breast-Conserving Surgery Using the Suture Scaffold Technique: A Single-Institution, Cross-Sectional Study.
    Ann Surg Oncol. 2022;29:3838.
    PubMed        

  24. WEISS A, King C, Grossmith S, Portnow L, et al
    ASO Visual Abstract: How Often Does Retrieval of a Clipped Lymph Node Change Adjuvant Therapy Recommendations? A Prospective Consecutive Patient Cohort Study.
    Ann Surg Oncol. 2022;29:3774-3775.
    PubMed        

  25. MITSUEDA R, Gen A, Fujiki Y, Gondo N, et al
    Satisfaction of Patients Who Received Breast-Conserving Surgery Using the Suture Scaffold Technique: A Single-Institution, Cross-Sectional Study.
    Ann Surg Oncol. 2022;29:3829-3835.
    PubMed         Abstract available

  26. MITSUEDA R, Gen A, Fujiki Y, Gondo N, et al
    ASO Author Reflections: Patients' Satisfaction After Breast Conserving Surgery Using the Suture Scaffold Technique.
    Ann Surg Oncol. 2022;29:3836-3837.
    PubMed        


    BMC Cancer

  27. ESER K, Onder AH, Sezer E, Cil T, et al
    Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients based on an observational study.
    BMC Cancer. 2022;22:516.
    PubMed         Abstract available

  28. BROWN J, Scardo S, Method M, Schlauch D, et al
    A real-world retrospective study of the use of Ki-67 testing and treatment patterns in patients with HR+, HER2- early breast cancer in the United States.
    BMC Cancer. 2022;22:502.
    PubMed         Abstract available

  29. ROUX A, Cholerton R, Sicsic J, Moumjid N, et al
    Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the "My Personal Breast Screening" (MyPeBS) randomised clinical trial.
    BMC Cancer. 2022;22:507.
    PubMed         Abstract available

  30. MITAL S, Nguyen HV
    Cost-effectiveness of using artificial intelligence versus polygenic risk score to guide breast cancer screening.
    BMC Cancer. 2022;22:501.
    PubMed         Abstract available

  31. MCLAUGHLIN PMJ, Klar M, Zwimpfer TA, Dutilh G, et al
    Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial.
    BMC Cancer. 2022;22:508.
    PubMed         Abstract available


    Breast Cancer

  32. HO PJ, Khng AJ, Tan BK, Tan EY, et al
    Relevance of the MHC region for breast cancer susceptibility in Asians.
    Breast Cancer. 2022 May 11. pii: 10.1007/s12282-022-01366.
    PubMed         Abstract available


    Breast Cancer (Dove Med Press)

  33. MANGONE L, Bisceglia I, Michiara M, Musolino A, et al
    Breast Cancer in Italy: Stage and Region Distribution.
    Breast Cancer (Dove Med Press). 2022;14:125-131.
    PubMed         Abstract available

  34. BAGEGNI NA, Davis AA, Clifton KK, Ademuyiwa FO, et al
    Targeted Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer: Spotlight on Pembrolizumab.
    Breast Cancer (Dove Med Press). 2022;14:113-123.
    PubMed         Abstract available


    Breast Cancer Res

  35. SYRIOPOULOU E, Gasparini A, Humphreys K, Andersson TM, et al
    Assessing lead time bias due to mammography screening on estimates of loss in life expectancy.
    Breast Cancer Res. 2022;24:15.
    PubMed         Abstract available

  36. ZHENG J, Zhang B
    Biological interpretation of prognostic radiomic score by correlating with tumor heterogeneity and microenvironment.
    Breast Cancer Res. 2022;24:32.
    PubMed        


    Breast Cancer Res Treat

  37. PARIKH DA, Kody L, Brain S, Heditsian D, et al
    Patient perspectives on window of opportunity clinical trials in early-stage breast cancer.
    Breast Cancer Res Treat. 2022 May 11. pii: 10.1007/s10549-022-06611.
    PubMed         Abstract available


    Cancer

  38. O'ROURKE K
    Compression sleeves reduce lymphedema after lymph node dissection: In women who had breast cancer surgery to remove their axillary lymph nodes, the sleeves helped prevent arm swelling: In women who had breast cancer surgery to remove their axillary ly
    Cancer. 2022;128:2049-2050.
    PubMed        

  39. HARBECK N, Burstein HJ, Hurvitz SA, Johnston S, et al
    A look at current and potential treatment approaches for hormone receptor-positive, HER2-negative early breast cancer.
    Cancer. 2022;128 Suppl 11:2209-2223.
    PubMed         Abstract available

  40. JOUNG RH, Nelson H, Mullett TW, Kurtzman SH, et al
    A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
    Cancer. 2022;128:2119-2125.
    PubMed         Abstract available


    Cancer Lett

  41. LIU Y, Zhang Z, Gao X, Ma Q, et al
    Corrigendum to "Rab8A promotes breast cancer progression by increasing surface expression of Tropomyosin-related kinase B" [Canc. Lett. 535 (2022) 215629].
    Cancer Lett. 2022 May 5:215701. doi: 10.1016/j.canlet.2022.215701.
    PubMed        


    Carcinogenesis

  42. ELISIA I, Yeung M, Wong J, Kowalski S, et al
    A low-carbohydrate diet containing soy protein and fish oil reduces breast but not prostate cancer in C3(1)/Tag mice.
    Carcinogenesis. 2022;43:115-125.
    PubMed         Abstract available


    Eur J Cancer

  43. SHAGISULTANOVA E, Gao D, Callihan E, Parris HJ, et al
    Overall survival is the lowest among young women with postpartum breast cancer.
    Eur J Cancer. 2022;168:119-127.
    PubMed         Abstract available


    Eur J Surg Oncol

  44. OZMEN T, Layton C, Friedman-Eldar O, Melnikau S, et al
    Evaluation of Simplified Lymphatic Microsurgical Preventing Healing Approach (SLYMPHA) for the prevention of breast cancer-related lymphedema after axillary lymph node dissection using bioimpedance spectroscopy.
    Eur J Surg Oncol. 2022 Apr 30. pii: S0748-7983(22)00424.
    PubMed         Abstract available

  45. MAIRE M, Debled M, Petit A, Fournier M, et al
    Neoadjuvant chemotherapy and radiotherapy for locally advanced breast cancer: Safety and efficacy of reverse sequence compared to standard technique?
    Eur J Surg Oncol. 2022 Apr 29. pii: S0748-7983(22)00415.
    PubMed         Abstract available


    Exp Cell Res

  46. CHEN L, Han S, Li Y, Zheng Y, et al
    SEZ6L2, regulated by USF1, accelerates the growth and metastasis of breast cancer.
    Exp Cell Res. 2022 May 3:113194. doi: 10.1016/j.yexcr.2022.113194.
    PubMed         Abstract available


    J Clin Oncol

  47. DAMODARAN S, Zhao F, Deming DA, Mitchell EP, et al
    Phase II Study of Copanlisib in Patients With Tumors With PIK3CA Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F.
    J Clin Oncol. 2022;40:1552-1561.
    PubMed         Abstract available

  48. LI S, Silvestri V, Leslie G, Rebbeck TR, et al
    Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants.
    J Clin Oncol. 2022;40:1529-1541.
    PubMed         Abstract available

  49. LIEBERMAN S, Goldvaser H, Levy-Lahad E
    Germline Pathogenic Variants in BRCA1 and BRCA2: Malignancies Beyond Female Breast and Ovarian Cancers.
    J Clin Oncol. 2022;40:1590-1594.
    PubMed        


    J Surg Oncol

  50. SAGUN A, Rumeli S, Ozdemir L, Azizoglu M, et al
    Intraoperative pectoral block thoracic paravertebral block for postoperative analgesia after breast cancer surgery: A randomized controlled trial.
    J Surg Oncol. 2022 May 10. doi: 10.1002/jso.26914.
    PubMed         Abstract available


    NPJ Breast Cancer

  51. HOOGSTRAAT M, Lips EH, Mayayo-Peralta I, Mulder L, et al
    Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance.
    NPJ Breast Cancer. 2022;8:60.
    PubMed         Abstract available

  52. LUNDGREN C, Bendahl PO, Church SE, Ekholm M, et al
    PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients.
    NPJ Breast Cancer. 2022;8:61.
    PubMed         Abstract available

  53. WAKS AG, Desai NV, Li T, Poorvu PD, et al
    A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer.
    NPJ Breast Cancer. 2022;8:63.
    PubMed         Abstract available

  54. LI Z, Spoelstra NS, Sikora MJ, Sams SB, et al
    Mutual exclusivity of ESR1 and TP53 mutations in endocrine resistant metastatic breast cancer.
    NPJ Breast Cancer. 2022;8:62.
    PubMed         Abstract available


    Oncogene

  55. SIMOND AM, Bui T, Zuo D, Sanguin-Gendreau V, et al
    Physiological expression of PI3K H1047R mutation reveals its anti-metastatic potential in ErbB2-driven breast cancer.
    Oncogene. 2022 May 10. pii: 10.1038/s41388-022-02323.
    PubMed         Abstract available


    PLoS One

  56. TAGHIZADEH MS, Niazi A, Moghadam A, Afsharifar A, et al
    Experimental, molecular docking and molecular dynamic studies of natural products targeting overexpressed receptors in breast cancer.
    PLoS One. 2022;17:e0267961.
    PubMed         Abstract available

  57. DAMASCENO KA, Santos-Conceicao AMD, Silva LP, Cardoso TMS, et al
    Factors related to the suppression of the antitumour immune response in female dogs with inflammatory mammary carcinoma.
    PLoS One. 2022;17:e0267648.
    PubMed         Abstract available


    Radiology

  58. KATAOKA M
    The Contribution of Imaging as a Prognostic Marker of Luminal Breast Cancer.
    Radiology. 2022 May 10:220748. doi: 10.1148/radiol.220748.
    PubMed        

  59. KWON BR, Shin SU, Kim SY, Choi Y, et al
    Microcalcifications and Peritumoral Edema Predict Survival Outcome in Luminal Breast Cancer Treated with Neoadjuvant Chemotherapy.
    Radiology. 2022 May 10:211509. doi: 10.1148/radiol.211509.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: